Viltacef 1.5gm Injection

Viltacef 1.5gm Injection

  • Each Combi Pack contains:
  • Vial Of Cefuroxime Sodium Injection IP
  • Cefuroxime Sodium IP (Sterile) EQ. To Anhydrous Cefuroxime 1500mg
  • One Ffs Ampoule Containing Sterile Water For Injection IP 20ml

Viltacef is a brand of Cefuroxime Sodium

Cefuroxime sodium is a second generation oral cephalosporin antibiotic. Cefuroxime sodium, a prodrug of the cephalosporin cefuroxime, has proven antibacterial activity against several Gram-positive and Gram-negative organisms, including those most frequently associated with various common community-acquired infections.

  • Dosage
  • Indications
  • Contraindication
  • Side-effects
  • Precautions
  • Storage
  • Adults: Many infections will respond to 750mg three times daily by intramuscular or intravenous injection. For more severe infections this dose should be increased to 1.5g three times daily intravenously. The frequency of dosage may be increased to six-hourly injections, intramuscular or intravenous, giving total daily doses of 3g to 6g.
  • Infants and children: Doses of 30 to 100mg/kg/day given in three or four divided doses. A dose of 60mg/kg/day will be appropriate for most infections.
  • Neonates: Doses of 30 to 100mg/kg/day given in two or three divided doses. In the first weeks of life the serum half-life of cefuroxime can be three to five times that in adults.
  • Gonorrhea: 1.5g should be given as a single dose or as two 750mg injections into different sites, eg, each buttock.
  • Meningitis: Cefuroxime therapy is suitable for sole therapy of bacterial meningitis due to sensitive strains.
  • Infants and children: 200 to 240mg/kg/day intravenously in three or four divided doses. This dosage may be reduced to 100mg/kg/day after three days or when clinical improvement occurs.
  • Neonates: The initial dosage should be 100mg/kg/day intravenously. This dosage may be reduced to 50mg/kg/day after three days or when clinical improvement occurs.
  • Adults: 3g intravenously every eight hours. No data is currently available to recommend a dose for intrathecal administration.
  • Bone and Joint infection
  • Urinary Tract infection
  • Meningitis
  • Lower RTI
  • Tonsilitis
  • Skin infection

It may not be recommended to consume Viltacef Tablet if you have the following diseases, medical or physical conditions:

  • Breastfeeding
  • Hypersensitivity to cephalosporin's
  • Pregnant

diarrhea, dizziness, headache, drowsiness, itching/swelling, rash, nausea, vomiting, abdominal pain, stomach upset, gas, headache, itching or rash, hives, cough, stuffy nose, stiff or tight muscles, muscle pain, joint pain or swelling, restlessness, irritability, hyperactivity.


Store medicines at room temperature, away from heat and direct light. Do not freeze medicines unless the packaging or storage instructions clearly require you to do that.

Get In Touch

Head Office

Viilbery Healthcare Pvt. Ltd. Plot No. P- 64, Milap Nagar,
M. I. D. C Residential Zone Near AIMS Hospital, Dombivili
East, Thane - 421 203, Maharashtra, India.

Phone No

+91-251-2424221 / 2446311 / 2434221